Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (5): 574-576.DOI: 10.3969/j.issn.1673-8640.2021.05.024
Previous Articles Next Articles
Received:2020-07-27
Online:2021-05-30
Published:2021-05-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.05.024
| [1] |
FANG L F, ZHANG P P, WANG J, et al. Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017[J]. Braz J Infect Dis, 2020,24(1):7-12.
DOI URL |
| [2] |
ALMEIDA A, FENAUX P, LIST A F, et al. Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes(MDS)[J]. Leuk Res, 2017,52:50-57.
DOI URL |
| [3] |
GIAGOUNIDIS A A, KULASEKARARAJ A, GERMING U, et al. Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide[J]. Leukemia, 2012,26(4):855-858.
DOI URL |
| [4] | 韩冰, 李红敏, 陈芳菲, 等. 骨髓增生异常综合征贫血原因及治疗策略[J]. 天津医药, 2018,46(8):794-798. |
| [5] | 中华医学会血液学分会. 骨髓增生异常综合征中国诊断与治疗指南(2019年版)[J]. 中华血液学杂志, 2019,40(2):89-97. |
| [6] | 宋慧娟, 张卫军, 牟锐, 等. MDS(5q-)伴环铁增多及SF3B1基因突变一例及治疗观察[J]. 临床医药文献电子杂志, 2019,6(86):179. |
| [7] | 贡蓉, 贺少龙, 王涛, 等. 环磷酰胺联合环孢素治疗输血依赖的MDS 5q合并自身免疫性溶血性贫血一例[J]. 山西医药杂志, 2017,46(23):2962-2963. |
| [8] | 年青, 王利. 伴del(5q)的骨髓增生异常综合征的分子生物学研究进展[J]. 重庆医科大学学报, 2015,40(4):542-545. |
| [9] |
GORSHEIN E, WEBER U M, GORE S. Higher-risk myelodysplastic syndromes with del(5q):does the del(5q) matter?[J]. Expert Rev Hematol, 2020,13(3):233-239.
DOI URL |
| [10] | 冯秀媛, 闫慧明, 王永福, 等. 系统性红斑狼疮血液系统受累的相关性分析[J]. 临床荟萃, 2011,26(23):2086-2088. |
| [11] | 杨朝荣. 误诊为血液系统疾病的系统性红斑狼疮临床分析[J]. 中国热带医学, 2010,10(9):1135. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
